β-Glucans in promoting health: Prevention against mutation and cancer

Cisneros, 1996, Passive transfer of poly-(1-6)-β-glucotriosyl-(1-3)-β-glucopyranose glucana protection against lethal infection in an animal model of intra-abdominal sepsis, Infect. Immun., 64, 2201, 10.1128/IAI.64.6.2201-2205.1996

Zimmerman, 1998, A novel carbohydrate–glycosphingolipid interaction between a β-(1-3)-glucan immunomodulador, PGG-glucan, and lactosylceramide of human leukocytes, J. Biol. Chem., 273, 22014, 10.1074/jbc.273.34.22014

Turnbull, 1999, The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines, Acta Haematol., 102, 66, 10.1159/000040972

Masihi, 2000, Immunomodulators in infectious diseases panoply of possibilities, Int. J. Immunopharmacol., 22, 1083, 10.1016/S0192-0561(00)00074-6

Zekovic, 2005, Natural modified (1→3)-β-glucans in health promotion and disease alleviation, Crit. Rev. Biotechnol., 25, 205, 10.1080/07388550500376166

Di Luzio, 1979, Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucana, Int. J. Cancer, 24, 773, 10.1002/ijc.2910240613

Sandula, 1995, Mitogenic activity of particulate yeast β-(1→3)-d-glucan and its water-soluble derivatives, Int. J. Biol. Macromol., 17, 323, 10.1016/0141-8130(96)81839-3

Tohamy, 2003, β-Glucan inhibits the genotoxicity of cyclophosphamide, adramycin and cisplatin, Mutat. Res., 541, 45, 10.1016/S1383-5718(03)00184-0

Keegstra, 2006, β-Glucans—brewer's bane, dietician’ delight, Science, 311, 1872, 10.1126/science.1125938

Ooi, 2000, Immunomodulation and anti-cancer activity of polysaccharide–proteins complexes, Curr. Med. Chem., 7, 715, 10.2174/0929867003374705

Chang, 2006, Structural and biological characterization of sulfated-derivatized oat β-glucan, J. Agric. Food Chem., 54, 3815, 10.1021/jf060243w

Kawagishi, 1989, Fraction and antitumoral activity of the water-insoluble reside of Agaricus blazei fruiting bodies, Carbohydr. Res., 186, 267, 10.1016/0008-6215(89)84040-6

Ohno, 2001, Antitumoral β-glucan from cultured fruit body of A. blazei, Biol. Pharm. Bull., 24, 820, 10.1248/bpb.24.820

Mizuno, 1990, Antitumoral activity and some properties of water-soluble polysaccharides from “Himematsutake”, the fruiting body of Agaricus blazei Murill, Agric. Biol. Chem., 54, 2889, 10.1271/bbb1961.54.2889

Camelini, 2005, Structural characterization of β-glucans of Agaricus brasiliensis in different stages of fruiting body maturity and their use in nutraceutical products, Biotechnol. Lett., 27, 1295, 10.1007/s10529-005-0222-6

Shin, 2005, Structural and biological characterization of aminated-derivatized oat β-glucan, J. Agric. Food Chem., 53, 5554, 10.1021/jf050273j

Zhang, 2003, Chain conformation of sulfated derivatives of beta-glucan from sclerotia of Pleurotus tuber-regium, Carbohydr. Res., 338, 2863, 10.1016/j.carres.2003.08.013

Wang, 2004, Correlation of structure to antitumoral activities of betaglucan from Poria cocos sclerotium, Carbohydr. Res., 339, 2567, 10.1016/j.carres.2004.08.003

Alban, 1994, Anticoagulant activities of beta-1,3-glucansulfates in dependence on their molecular weight, Pure Appl. Chem., 66, 2403, 10.1351/pac199466102403

Alban, 1995, Anticoagulant and antithrombotic activity actions of a semisynthetic beta-1,3-glucan sulfate, Thromb. Res., 78, 201, 10.1016/0049-3848(95)00049-W

Martinichen-Herrero, 2005, Anticoagulant and antithrombotic activity of a sulfate obtained from a glucan component of the lichen Parmotrema mantiqueirense Hale, Carbohydr. Polym., 60, 7, 10.1016/j.carbpol.2004.11.014

Miura, 2003, Structure and biological activities of β-glucans from yeast and mycelial forms of Candida albicans, Microbiol. Immunol., 47, 173, 10.1111/j.1348-0421.2003.tb03382.x

Brown, 2003, Fungal β-glucans and mammalian immunity, Immunity, 19, 311, 10.1016/S1074-7613(03)00233-4

Reynolds, 1980, Glucan-induced enhancement of host resistance to selected infectious diseases, Infect. Immun., 30, 51, 10.1128/IAI.30.1.51-57.1980

Meira, 1996, The use of glucan as immunostimulant in treatment of paracoccidiomycosis, Am. J. Trop. Med. Hyg., 55, 496, 10.4269/ajtmh.1996.55.496

Yun, 1998, Immunomodulatory effects of a oat-β-glucan administered intragastrically or parentally on mice infected with Eimeria verminoformis, Microbiol. Immunol., 42, 457, 10.1111/j.1348-0421.1998.tb02309.x

Soltýs, 1996, Effect of glucan immunomodulator on the immuno response and larval burdens in mice experimental toxocaris, Appl. Parasitol., 37, 161

Bohn, 1995, (1→3)-β-d-Glucans as biological response modifiers: a review of structure–functional activity relationships, Carbohydr. Polym., 28, 3, 10.1016/0144-8617(95)00076-3

Falch, 2000, The cytokine stimulating activity of (1→3)-β-d-glucans is dependent on the triple helix conformation, Carbohydr. Res., 329, 587, 10.1016/S0008-6215(00)00222-6

Tokunaka, 2000, Immunopharmacological and immunotoxicological activities of a water soluble (1→3)-β-glucan, CSBG from Candida albicans, Int. J. Immunopharmacol., 22, 383, 10.1016/S0192-0561(99)00093-4

Kubala, 2003, The effect of (1→3)-β-d-glucans, carboxymethylglucan and schizophyllan on human leukocytes in vitro, Carbohydr. Res., 338, 2835, 10.1016/j.carres.2003.09.007

Luhm, 2006, β-(1→3)-d-Glucan modulates DNA binding of nuclear factors kB, AT and IL-6 leading to an anti-inflammatory shift of the IL-Iβ/IL-1 receptor antagonist ratio, BMC Immunol., 7, 1, 10.1186/1471-2172-7-5

Chae, 2006, Effects of supplementation of β-glucan on the growth performance and immunity in broilers, Res. Vet. Sci., 80, 291, 10.1016/j.rvsc.2005.07.008

Grinde, 2006, Effects on gene expression and viral load of a medicinal extract from Agaricus blazei in patients with chronic hepatitis C infection, Int. Immunopharmacol., 6, 1311, 10.1016/j.intimp.2006.04.005

Kuo, 2002, Cell cycle progression and cytokine gene expression of human peripheral blood mononuclear cells modulated by Agaricus blazei, J. Lab. Clin. Med., 140, 176, 10.1067/mlc.2002.126717

Bernardshaw, 2006, An extract of the mushroom Agaricus blazei Murill protects against lethal septicemia in a mouse model for fecal priotonitis, Shock, 24, 319

Liang, 1998, Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats tested with PGG-glucan is associated with increased leukocyte counts and increased neutophil oxidative burst activity, Int. J. Immunopharmacol., 20, 595, 10.1016/S0192-0561(98)00007-1

Kaiser, 1998, Synergism between poly-(1→6)-β-d-glucopyranose glucana and cefazolin in prophylaxis of staphylococcal wound infection in guinea pig model, Antimicrobiol. Agents Chemother., 42, 2449, 10.1128/AAC.42.9.2449

Alban, 2001, Partial synthetic glucan sulfates as potential new antithrombotics: a review, Biomacromolecules, 2, 354, 10.1021/bm010032u

Colliec- Jouault, 2001, Characterization chemical modifications and in vivo anticoagulant properties of exopolysaccharide produced by Alteromonas infernos, Biochim. Biophys. Acta, 1528, 141, 10.1016/S0304-4165(01)00185-4

Oliveira, 2006, Evaluation of antimutagenic activity and mechanisms of action of β-glucan from barley, in CHO-K1 and HTC cell lines using the micronucleus test, Toxicol. In Vitro, 20, 1225, 10.1016/j.tiv.2006.04.001

Angeli, 2006, Protective effects of β-glucan extracted from Agaricus brasiliensis against chemically induced DNA damage in human lymphocytes, Cell Biol. Toxicol., 22, 285, 10.1007/s10565-006-0087-z

Oliveira, 2006, Protective effect of β-glucan extracted from Saccharomyces cerevisiae, against DNA damage and cytotoxicity in wild-type (K1) and repair-deficient (xrs5) CHO cells, Toxicol. In Vitro, 21, 41, 10.1016/j.tiv.2006.07.018

Krizkova, 2006, Antioxidant and antimutagenic activity of mannan neoglycoconjugates: mannan–human serum albumin and mannan–penicillin G acylase, Mutat. Res., 606, 72, 10.1016/j.mrgentox.2006.03.003

Davegowda, 1998, Mycotoxins: novel solutions for their counteraction, Feedstuffs, 70, 12

Chorvatovicová, 1991, Suppressing effects of glucan on micromuceli induced by Co60 in mice, Stranhlenther Onkol., 167, 612

Slamenová, 2003, Protective effects of fungal β-d-glucan derivatives against oxidative DNA lesions in V79 hamster lung cells, Cancer Lett., 198, 153, 10.1016/S0304-3835(03)00336-7

Angeli, 2006, Anti-clastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells, Hum. Exp. Toxicol., 25, 319, 10.1191/0960327106ht631oa

Hashimoto, 2002, Suppressive effect of polysaccharides from the edible and medicinal mushrooms, Lentinus edodes and Agaricus blazei, on the expression of cytochrome P450s in mice, Biosci. Biotechnol. Biochem., 344, 610

Okamoto, 2004, Lentinan from shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver, Biofactors, 21, 407, 10.1002/biof.552210180

Kiho, 1998, Biological activities of (1→3)-β-d-glucan with reducing glucose side chains, Biosci. Biotechnol. Biochem., 62, 570, 10.1271/bbb.62.570

Zhang, 2005, Correlation between antitumoral activity, molecular weight, and conformation of lentinan, Carbohydr. Res., 340, 1515, 10.1016/j.carres.2005.02.032

Sener, 2006, β-glucan ameliorates methotrexate-induced oxidative organ injury via its antioxidant and immunomodulatory effects, Eur. J. Pharmacol., 542, 170, 10.1016/j.ejphar.2006.02.056

Davidson, 1991, The hypocholesterolemic effects of beta-glucan in oatmeal and oat bran. A dose-controlled study, JAMA, 265, 1079, 10.1001/jama.265.14.1833